Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Iovance Biotherapeutics, Inc. - Common Stock
(NQ:
IOVA
)
4.380
+0.590 (+15.57%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 4, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Iovance Biotherapeutics, Inc. - Common Stock
< Previous
1
2
...
17
18
19
20
21
22
23
24
Next >
Iovance Biotherapeutics to Present at Upcoming Conferences
April 24, 2023
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Wall Street Thinks These 2 Nasdaq Stocks Could Go Parabolic Soon
↗
April 20, 2023
These two biotech stocks might be significantly undervalued.
Via
The Motley Fool
Why Shares of Iovance Biotherapeutics Jumped Monday
↗
March 27, 2023
The company filed a Biologics License Application to the FDA for its lead therapy.
Via
The Motley Fool
Why Iovance Biotherapeutics Shares Are Trading Higher Today
↗
March 27, 2023
Iovance Biotherapeutics (NASDAQ: IOVA) shares are trading higher on Monday after the company completed its Biologics License Application submission for lifileucel.
Via
Benzinga
Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
March 27, 2023
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 59.6% to $0.2513. Crown Electrokinetics said it has entered into an agreement with a leading infrastructure solutions provider.
Via
Benzinga
Analyst Expectations for Iovance Biotherapeutics's Future
↗
March 27, 2023
Via
Benzinga
Why Motorsport Games Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket
↗
March 27, 2023
Gainers Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) shares rose 38.5% to $2.05 in pre-market trading after gaining 8% on Friday.
Via
Benzinga
First Republic Bank, KeyCorp And Other Big Stocks Moving Higher In Monday's Pre-Market Session
↗
March 27, 2023
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Iovance Biotherapeutics Completes Biologics License Application (BLA) Submission for Lifileucel in Advanced Melanoma
March 24, 2023
First TIL Therapy BLA Submission to U.S. Food and Drug Administration
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Expert Ratings for Iovance Biotherapeutics
↗
March 06, 2023
Via
Benzinga
The Latest Analyst Ratings for Iovance Biotherapeutics
↗
January 24, 2023
Via
Benzinga
What 6 Analyst Ratings Have To Say About Iovance Biotherapeutics
↗
December 09, 2022
Via
Benzinga
What 4 Analyst Ratings Have To Say About Iovance Biotherapeutics
↗
November 21, 2022
Via
Benzinga
Iovance Biotherapeutics to Present at Upcoming Conferences
March 01, 2023
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Updates
February 28, 2023
First Biologics License Application (BLA) Submission on Track to Complete in 1Q23
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Iovance Biotherapeutics to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on Tuesday, February 28, 2023
February 21, 2023
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023
↗
January 27, 2023
Via
Benzinga
American Express, Visa And Other Big Stocks Moving Higher In Friday's Pre-Market Session
↗
January 27, 2023
U.S. stock futures traded slightly lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Why Iovance Biotherapeutics Stock Soared 12% Higher Today
↗
January 23, 2023
A business, clinical, and regulatory update lifted the spirits of investors.
Via
The Motley Fool
Iovance Biotherapeutics Acquires Clinigen's IL-2 Product For Upfront £166.7M
↗
January 23, 2023
Via
Benzinga
Iovance Biotherapeutics Provides Corporate, Clinical, and Regulatory Updates
January 23, 2023
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Why Is Iovance Biotherapeutics (IOVA) Stock Soaring 20% Today?
↗
December 05, 2022
Although Iovance Biotherapeutics cuts a speculative figure, IOVA stock managed to skyrocket on Monday off insider buying.
Via
InvestorPlace
Why Iovance Biotherapeutics Shares Are Trading Higher By Around 19%? Here Are 40 Stocks Moving In Monday's Mid-Day Session
↗
December 05, 2022
Gainers Winc, Inc. (NYSE: WBEV) rose 88.5% to $0.3901 after dropping over 23% on Friday. Winc, last month, posted a Q3 loss of $0.33 per share.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
December 05, 2022
Via
Benzinga
US Stocks Start Week On Lower Note; Dow Tumbles 250 Points
↗
December 05, 2022
U.S. stocks traded lower this morning, with the Dow Jones falling around 250 points on Monday.
Via
Benzinga
Iovance Biotherapeutics Stock Is Surging: Here's Why
↗
December 05, 2022
Iovance Biotherapeutics Inc (NASDAQ: IOVA) shares are trading higher Monday following recent insider buying from Director Wayne Rothbaum.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
December 05, 2022
Via
Benzinga
$65 Million Bet On Iovance Biotherapeutics? Check Out These 3 Stocks Insiders Are Buying
↗
December 05, 2022
Although US stocks closed mixed on Friday, there were a few notable insider trades.
Via
Benzinga
Iovance Biotherapeutics to Present at Upcoming Conferences
November 30, 2022
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
NIO To Surge Around 105%? Plus Keybanc Predicts $165 For This Stock
↗
November 21, 2022
Keybanc raised the price target on AMETEK, Inc. (NYSE: AME) from $145 to $165. Keybanc analyst Steve Barger maintained an Overweight rating on the stock. AMETEK shares rose 0.9% to close at $139.32 on...
Via
Benzinga
< Previous
1
2
...
17
18
19
20
21
22
23
24
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
